Are GMO-free Cheerios the first domino?

Activists are trumpeting General Mills’ decision to remove GMOs from Cheerios as a watershed moment. It is; but not for the reason that they believe.

The move was relatively easy and inexpensive. Cheerios are primarily oats, and there are no GMO oats. The comparatively small amounts of sugar and cornstarch in the mix required nothing more than a switch from beet sugar to non-GMO sources. At the same time, Cheerios popularity among parents transitioning their children to solid food leaves the product more vulnerable to activist attacks, and in turn justifies a modest investment that might provide a slight marketing boost and a modicum of brand protection.

Add the ubiquitous use of GMOs today (they are found in as much as 80 percent of the processed foods we eat) – and the degree of difficulty in removing them from just about every other product on the shelves – and it’s hard to see Cheerios as a domino or test case. But it isn’t the proverbial tree falling in a forest either. When we shift the focus from General Mills motivations to the timing of its decision, we see why every food manufacturer ought to be taking notice, whether another brand-name kitchen table staple goes non-GMO or not.

Read the full, original article: Are GMO-Free Cheerios the First Domino?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.